Neuropilin-1 (np1) and neuropilin-2 (np2) are receptors for class-3 semaphorins and for several isoforms of VEGF. We have cloned and characterized two chick isoforms of np2 cDNA. Expression patterns of np1, np2, and ephrin-B2 were compared in the developing vascular system of 24-72 h old chick embryos. We show for the first time that np2 is expressed in blood vessels in vivo from the earliest stages of their formation. In contrast to ephrin-B2, both np1 and np2 are expressed in blood islands of 24 h old chick embryos. At 48-72 h, np1 expression is localized preferentially in arteries with an expression pattern that resembles that of ephrin-B2. In contrast, np2 is expressed preferentially in veins. Thus, neuropilins may play a role in determining the arterial or venous identity of blood vessels. q
Results and discussion
Neuropilin-1 (np1) and neuropilin-2 (np2) are cell surface receptors for class-3 semaphorins (Nakamura et al., 2000) and for certain heparin binding forms of VEGF (GluzmanPoltorak et al., 2000; Soker et al., 1998) . Furthermore, np1 functions as an accessory receptor that enhances VEGF stimulated responses mediated by the VEGFR-2 tyrosinekinase VEGF receptor (Soker et al., 1998; Yamada et al., 2001) , possibly as a result of complex formation between VEGFR-2 and np1 (Whitaker et al., 2001) . Np1 also forms complexes with a second VEGF receptor, VEGFR-1 (Fuh et al., 2000) . Mice lacking np1 exhibit deficiencies in the development of their cardiovascular system since np1 is required for VEGF induced vasculogenesis and angiogenesis (Kawasaki et al., 1999; Yamada et al., 2001) . The related np2 also functions as a splice-form specific VEGF receptor (Gluzman-Poltorak et al., 2000) and forms complexes with the VEGFR-1 receptor (Gluzman-Poltorak et al., 2001) . Np2 is expressed by human endothelial cells derived from umbilical veins (Gluzman-Poltorak et al., 2000) , but mice lacking np2 are viable and do not suffer gross cardiovascular malformations (Chen et al., 2000; Giger et al., 2000) . Thus, the role played by np2 in the cardiovascular system remains unclear.
Cloning of two chick np2a isoforms
To characterize the expression pattern of the np2 gene we first cloned the chick np2 cDNA homologue. In mice, np2 is expressed as two basic splice forms, a and b, characterized by different transmembrane and cytoplasmic domains (Chen et al., 1997) . In addition, each basic np2 form has insertions of 5, 17 or 22 amino-acids at amino-acid 809 of the juxtamembrane part of the C domain (arrow, Fig. 1A ) (Chen et al., 1997) . We cloned two forms of np2a chick cDNA. The overall homology between the human and the chick np2 sequences at the amino-acids level is about 77% (Fig.  1A) . The shortest of these chick np2 isoforms, chnp2a1, contains an insertion of 22 amino-acids at a position corresponding to the 22 amino-acids insertion found in human np2a22. However, the sequence of these 22 amino-acids in the chick np2 cDNA is highly divergent from that of the human and mouse inserts (Fig. 1B, empty arrow) . In addition chnp2a1 lacks an insertion of 17 amino-acids that are present in all human and mouse np2 isoforms. These 17 amino-acids are present in chnp2a2 although the sequence is highly divergent with that of human and mouse np2 (Fig.  1B, black arrow) . Whole-mount in situ hybridization with probes for np1, np2 and ephrin-B2 was used to study expression of these genes in the vasculature of chick embryos. In two somitestage embryos np1 is clearly expressed in the heart forming region (HFR) (Fig. 2A) . Both np1 and np2 are expressed in blood islands (BI) located in the area vasculosa (AV) ( Fig.  2A,B) , but ephrin-B2, an arterial marker (Wang et al., 1998) is not (Fig. 2C ). This observation is consistent with previous reports in which it was found that vasculogenesis is not affected in mice lacking a functional ephrin-B2 gene (Wang et al., 1998 ).
Characterization of np1, np2 and ephrin-B2 expression in blood vessels of 48-72 h old chick embryos
Np1 mRNA is strongly expressed in the vitelline arteries (VA) as well as in smaller branches of these arteries in 48 h old embryos (Fig. 3B; and A. Eichmann, unpublished observations) . In contrast, np2 is localized to the vitelline veins as well as to smaller veins that merge with them (VV) (Fig.  3A) . Hence, np1 and np2 differentially label developing arteries and veins, respectively. There was also low level expression of np1 in the heart (not shown) as well as in proximal regions of the vitelline veins ( Fig. 3B , arrow). The expression of the arterial marker ephrin-B2 (Wang et al., 1998) in arteries matches that of np1 (Fig. 3C ). Double in situ hybridization revealed that arteries express predominantly np1 (blue stain) while veins express predominantly np2 (red stain) (Fig. 3D) , and that at the boundary between arteries and veins, expression of both neuropilins is down regulated (Fig. 3E, arrows) . This observation may indicate that at the boundary, artery derived factors suppress np2 expression and vice-versa. At this stage, blood islands located at the caudal end of 48 h old embryos express predominantly np2 (Fig. 3A,D) and very little np1 (Fig. 3B,D , arrowheads) . No ephrin-B2 was detected in these blood islands (Fig. 3C) . We also sectioned 2 and 3 day-old embryos following whole-mount in situ hybridization. The dorsal aorta of 2 day old embryos expresses np1 mRNA but no np2 mRNA. In contrast, the cardinal vein expresses low levels of np2 mRNA but no np1 mRNA (not shown). This pattern is even more pronounced in 3 day-old embryos in which strong np2 expression is seen in the cardinal veins (Fig.  4A,B ). Higher magnification reveals that both np1 and np2 are expressed in endothelial cells of the dorsal aorta and cardinal vein respectively (Fig. 4C,D) . A similar differential expression pattern of np1 versus np2 was also observed in the prospective subclavian arteries and veins of 4 day-old chick embryos. These blood vessels were identified as arteries and veins by following transverse sections up to their origin in the dorsal aorta and the posterior cardinal veins respectively (not shown). In addition there was at this stage strong expression of np1, but not of np2, in the heart (not shown).
In summary, we show for the first time that np2 is expressed in vivo in blood islands from the earliest stages of blood vessel formation, and subsequently in embryonic blood vessels. Our experiments indicate that in embryonic days 2 and 3 the expression of np1 is confined to arteries while that of np2 is confined to veins, suggesting that neuropilins play a role in arterial and venous blood vessel differentiation. Specific VEGF isoforms like VEGF 145 which differentiate between np1 and np2 as well as semaphorins may also play a role (Gluzman-Poltorak et al., 2000) . Preliminary experiments from our laboratory indicate that np2 expression may be down regulated at later stages of blood vessel development. Mice lacking the np2 gene do not display gross deformations in their vascular systems (Chen et al., 2000; Giger et al., 2000) (Ginty and Kolodkin, pers. commun.) . It is therefore possible that the function of np2 in blood vessel formation is transient and redundant with that of another gene. Fig. 3 . Np1 is expressed in extra-embryonic arteries while np2 is expressed in extra-embryonic veins of 22-25 somite embryos. Whole-mount in situ hybridization of 22-25 somite embryos: (A) Np2 is expressed in the vitelline vein (VV) and in blood islands at the caudal part of the area pellucida and area opaca. (B) Np1 expression is seen in the vitelline artery (VA), and weak expression is also seen in proximal regions of the vitelline veins (VV) (arrow). Weak expression is also seen in some caudal blood islands (arrowheads). (C) Ephrin-B2 expression is seen in the vitelline artery but not in blood islands. (D) Double whole-mount in situ hybridization reveals np1 expression in the vitelline artery and its tributaries (blue). Np2 expression is seen in the vitelline vein and in smaller veins (red) and does not overlap with np1 expression. Strong np2 staining is seen in blood islands near the caudal end of the embryo. Some blood islands show double staining for both np1 and np2 (arrowheads). (E) Higher magnification of boxed area of panel D. Arrows show the boundary between arteries and veins.
Methods

Embryos
Fertilized chick (Gallus gallus) eggs from commercial sources were used for this study.
Cloning of the chick np2 cDNA isoforms
First strand DNA was synthesized from 1 mg of total RNA from 6 day-old embryos using random hexanucleotides. Reverse transcription was performed using 200 units of MMLV-RT (Gibco-BRL) as described (GluzmanPoltorak et al., 2000) . Amplification of one part of the chnp2 cDNA was done first using a 5 0 primer corresponding to human np2 nucleotides 1250-1271 and the 3 0 primer GCTCTAGAGTCGACTCATGCCTCGGAGCAGCACT-T. A second piece of the cDNA was amplified using the chnp2 derived primer CCAGTCGTAGCCTCTGATA-GAAG and the 5 0 primer CCCCGAACCCAACCAGAA-GANN. This procedure was repeated three times to detect mistakes generated by PCR. The products of the second RT-PCR were joined with the 3 0 part using a common Bgl-II site, and ligated into a pBluescript-SK Plasmid (Stratagene).
To obtain the 5 0 end of the cDNA we used a rapid amplification of cDNA ends (RACE) kit (Boehringer Mannheim) and the primer TTGTAGATCTCATAGCGCAGGG. The cDNA was amplified using an internal primer TGCTTC-GCTGTCTCCATCTCGG and a poly-T primer, and ligated into the Xho-I site of the chnp2a1 form to generate the pchnp2a1 plasmid containing full length chnp2a1.
Cloning of np1 and ephrin-B2 chick cDNA probes
The same procedure as above was used to clone np1 and ephrin-B2 chick cDNA probes. Primers corresponding to nucleotides 1371-1390 and 2383-2402 of the np1 cDNA (Takagi et al., 1995) and nucleotides 20-40 and 966-986 of the Ephrin-B2 cDNA (accession number AF180729) were used. The cDNA probes were cloned into the pGEMTeasy plasmid (Promega).
Preparation of cRNA probes for whole-mount in situ hybridization
The DIG RNA labeling kit of Boehringer Mannheim and the T7 promoter of the PCR2.1 plasmid containing the 3 end of the chnp2a2 cDNA were used to prepare the fluorescein or digoxigenin-labeled np2 cRNA probe. Np1 and ephrin-B2 digoxigenin labeled cRNA probes were produced similarly using the SP6 promoter of the pGEMTeasy plasmid.
Whole-mount in situ hybridization
Whole-mount in situ hybridization was performed as described (Kahane et al., 1998a,b) using chick-specific cRNA probes for np1, np2 and ephrin-B2. The extraembryonic membranes were not stripped and the proteinase-K digestion step was omitted in experiments in which extra-embryonic blood vessels were probed for mRNA expression. Embryos were subsequently embedded in paraffin-wax and sectioned at 7 mm. Double in situ whole-mount hybridizations followed the procedure described by Dietrich et al. (1997) .
